Milestone:   

2009 - Incorporation of Alseal, in Besançon - France
2009 - CE mark for HQS Endovalve
2009 - First clinical use of HQS Endovalve - Monaco
2010 - CE mark for pre-dilators
2010 - Successful trials - Bordeaux, Paris, Marseille
2010 - HQS Endovalve awarded at CX Vascular Symposium (London) innovating show case
2011 - CE mark for XCath
2011 - Setting-up export department - Trials - Italy, Netherland, Germany, ...
2011 - XCath awarded at CX Vascular Symposium (London) innovating show case
2012 - Trials - Sweden, UK, Hong-Kong, Switzerland, ...
2012 - Moving to new offices at Bioparc in Besançon - France